-
Prediction of recurrent preeclampsia using first-trimester uterine artery Doppler.
Demers S, Bujold E, Arenas E, Castro A, Nicolaides KH.
Am J Perinatol 2014;31:99-104. -
First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing.
Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2014;35:118-26. pdf -
Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis.
Struble CA, Syngelaki A, Oliphant A, Song K, Nicolaides KH.
Fetal Diagn Ther 2014;35:199-203. pdf -
Embryo reduction in dichorionic triplets to dichorionic twins by intrafetal laser.
Chaveeva P, Kosinski P, Birdir C, Orosz L, Nicolaides KH.
Fetal Diagn Ther 2014;35:83-6. pdf -
Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies.
Gil MM, Quezada MS, Bregant B, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2014;35:204-11. pdf -
Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis.
Nicolaides KH, Musci TJ, Struble CA, Syngelaki A, Gil MM.
Fetal Diagn Ther 2014;35:1-6. pdf -
A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy.
Dixon PH, Wadsworth CA, Chambers J, Donnelly J, Cooley S, Buckley R, Mannino R, Jarvis S, Syngelaki A, Geenes V, Paul P, Sothinathan M, Kubitz R, Lammert F, Tribe RM, Ch'ng CL, Marschall HU0, Glantz A, Khan SA, Nicolaides K, Whittaker J, Geary M, Williamson C.
Am J Gastroenterol 2014;109:76-84. pdf -
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C, Rossler J.
FASEB J 2002;16:1271-3. -
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2002;22:877-9. -
Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester.
Souka AP, Skentou H, Geerts L, Bower S, Nicolaides KH.
Prenat Diagn 2002;22:93-5. -
Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.
Souka AP, Krampl E, Geerts L, Nicolaides KH.
Prenat Diagn 2002;22:91-2. -
Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies.
Souka AP, Raymond FL, Mornet E, Geerts L, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:294-5. -
Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.
Souka AP, Bower S, Geerts L, Huggon I, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:197-9. -
Trichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management.
Papageorghiou AT, Liao AW, Skentou C, Sebire NJ, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:307-12. -
Increased fetal nuchal translucency at 11-14 weeks.
Nicolaides KH, Heath V, Cicero S.
Prenat Diagn 2002;22:308-15. -
One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
Nicolaides KH, Bindra R, Heath V, Cicero S.
J Matern Fetal Neonatal Med 2002;12:9-18. -
Fetal cardiac abnormalities identified prior to 14 weeks' gestation.
Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:22-9. -
Monozygotic twins discordant for body stalk anomaly.
Daskalakis GJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:79-81. -
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks.
Bindra R, Heath V, Nicolaides KH.
Clin Obstet Gynecol 2002;45:661-70.